Affected Systems |
|
|
|
endocrine/exocrine glands
|
|
√
|
insulitis
|
|
√
|
growth/size/body
|
√
|
|
decreased body size
|
√
|
|
hematopoietic system
|
√
|
√
|
abnormal T cell differentiation
|
|
√
|
increased neutrophil cell number
|
√
|
|
increased effector memory T-helper cell number
|
|
√
|
increased osteoclast cell number
|
√
|
|
abnormal T cell activation
|
|
√
|
abnormal osteoclast physiology
|
√
|
|
homeostasis/metabolism
|
|
√
|
impaired glucose tolerance
|
|
√
|
immune system
|
√
|
√
|
abnormal T cell activation
|
|
√
|
abnormal immune system morphology
|
√
|
|
abnormal T cell differentiation
|
|
√
|
increased neutrophil cell number
|
√
|
|
increased effector memory T-helper cell number
|
|
√
|
increased osteoclast cell number
|
√
|
|
abnormal Peyer's patch morphology
|
√
|
|
enlarged Peyer's patches
|
√
|
|
abnormal professional antigen presenting cell physiology
|
|
√
|
abnormal dendritic cell physiology
|
|
√
|
increased interleukin-12b secretion
|
√
|
|
increased interleukin-6 secretion
|
√
|
|
increased tumor necrosis factor secretion
|
√
|
|
increased susceptibility to autoimmune diabetes
|
|
√
|
increased anti-insulin autoantibody level
|
|
√
|
abnormal inflammatory response
|
√
|
|
insulitis
|
|
√
|
increased susceptibility to endotoxin shock
|
√
|
|
abnormal innate immunity
|
√
|
|
abnormal osteoclast physiology
|
√
|
|
limbs/digits/tail
|
√
|
|
decreased diameter of femur
|
√
|
|
skeleton
|
√
|
|
increased osteoclast cell number
|
√
|
|
abnormal osteoclast physiology
|
√
|
|
decreased diameter of femur
|
√
|
|
kyphosis
|
√
|
|
abnormal compact bone morphology
|
√
|
|
decreased compact bone thickness
|
√
|
|
increased osteoblast cell number
|
√
|
|
abnormal trabecular bone morphology
|
√
|
|
decreased trabecular bone volume
|
√
|
|